2991 - 3000 of 7916 Results
Title
Year
- Exploring new uses for existing drugs: innovative mechanisms to fund independent clinical research2021OPENTitle: Exploring new uses for existing drugs: innovative mechanisms to fund independent clinical researchJournal Name: TrialsPublisher: Springer Science and Business Media LLCVol: 22Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13063-021-05273-xBest OA location URL: https://trialsjournal.biomedcentral.com/counter/pdf/10.1186/s13063-021-05273-xCitation Count: 22
-
RESTRICTEDTitle: Investigating Cognitive Global Coordination in normal and autistic children using virtual reality environments – An EEG StudyJournal Name: 2021 10th International IEEE/EMBS Conference on Neural Engineering (NER)Publisher: IEEEVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1109/ner49283.2021.9441259Citation Count: 1
-
OPENTitle: Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1972End Page: 1978Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28608Best OA location URL: https://europepmc.org/articles/pmc8453505?pdf=renderCitation Count: 18
-
OPENTitle: Genomewide Association Studies of LRRK2 Modifiers of Parkinson's DiseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 90Issue #: 1Start Page: 76End Page: 88Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/ana.26094Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.26094Citation Count: 36
-
RESTRICTEDTitle: Ischemic Events After Intracerebral HemorrhageJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 78Issue #: 7Start Page: 795End Page: 795Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2021.0772Citation Count: 3
-
RESTRICTEDTitle: A New Approach to the Development of Disease‐Modifying Therapies for PDJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 5Start Page: 1281End Page: 1281Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28589Citation Count: 1
-
OPENTitle: Alzheimer's Disease Alters Oligodendrocytic Glycolytic and Ketolytic Gene ExpressionJournal Name: The FASEB JournalPublisher: WileyVol: 35Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1096/fasebj.2021.35.s1.02461Best OA location URL: https://digitalcommons.wustl.edu/context/oa_4/article/3325/viewcontent/Alzheimer_s___Dementia___2021___Saito___Alzheimer_s_disease_alters_oligodendrocytic_glycolytic_and_ketolytic_gene.pdfCitation Count: 1
- Assessment of the Impact of Tardive Dyskinesia in Clinical Practice: Consensus Panel Recommendations2021RESTRICTEDTitle: Assessment of the Impact of Tardive Dyskinesia in Clinical Practice: Consensus Panel RecommendationsJournal Name: Neuropsychiatric Disease and TreatmentPublisher: Informa UK LimitedVol: Volume 17Issue #:Start Page: 1589End Page: 1597Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.2147/ndt.s310605Best OA location URL: https://www.dovepress.com/getfile.php?fileID=69709Citation Count: 13
-
RESTRICTEDTitle: Biomedical Research Must Change — But a Shift Toward Human-specific Research Methods Is Only Part of What Is NeededJournal Name: Alternatives to Laboratory AnimalsPublisher: SAGE PublicationsVol: 49Issue #: 3Start Page: 69End Page: 72Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/02611929211030417Citation Count: 5
-
OPENTitle: Cerebral dopamine neurotrophic factor reduces α-synuclein aggregation and propagation and alleviates behavioral alterations in vivoJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 29Issue #: 9Start Page: 2821End Page: 2840Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ymthe.2021.04.035Best OA location URL: http://www.cell.com/article/S1525001621002495/pdfCitation Count: 33